Navigation Links
New analysis shows that patients with Type 2 diabetes and mild renal impairment had similar improvement in blood sugar control and experienced less hypoglycemia with JANUVIA (sitagliptin) compared to sulfonylurea
Date:6/22/2013

h a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk of developing pancreatitis while taking JANUVIA. There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with JANUVIA or with any other antidiabetic drug.

Design of Post-hoc Analysis

This post-hoc analysis pooled data from three randomized, double-blind studies conducted over 25-30 weeks that included 1,180 patients with type 2 diabetes and mild renal insufficiencyii. The analysis compared the effects of JANUVIA 100 mg (n=584) once daily to a sulfonylurea, either glipizide or glimepiride (n=596) in titrated doses, on change from baseline in A1C, fasting plasma glucose, body weight, and the incidence of symptomatic hypoglycemia.

Selected Important Risk Information About JANUVIA (sitagliptin) 50 mg, 100 mg tablets

JANUVIA is contraindicated in patients with a history of a serious hypersensitivity reaction to sitagliptin, such as anaphylaxis or angioedema.

There have been postmarketing reports of acute pancreatitis, including fatal and nonfatal hemorrhagic or necrotizing pancreatitis, in patients taking JANUVIA. After initiating JANUVIA (sitagliptin), observe patients carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, promptly discontinue JANUVIA and initiate appropriate management. It is unknown whether patients with a history of pancreatitis are at increased risk of developing pancreatitis while taking JANUVIA.

Assessment of renal function is recommended prior to initiating JANUVIA and periodically thereafter. A dosage adjustment is recommended in patients with moderate or severe renal insufficiency and in patients with end-stage renal disease requiring hemodialysis or peritoneal dialysis. Caution should be used to ensure that the correct dose of JANUVIA is prescribed.

There have been postmarketing repor
'/>"/>

Contact: Pam Eisele
908-423-5042

Kim Hamilton
908-423-6831
908-391-0131

Carol Ferguson
908-423-4465

Merck


Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. New Avalere Analysis: Top Five Medicare Part D Plans with the Lowest Average Premiums Have Preferred Pharmacy Networks
2. Novel Drug Delivery Systems Market (NDDS): Formulations (Oral & Injectable) Analysis in Research Report at RnRMarketResearch.com
3. China Animal Vaccine Market Analysis to 2017 in New Research Report at ReportsnReports.com
4. Fulgent Therapeutics Announces Their Comprehensive Hereditary Cancer Test Including BRCA1 and BRCA2 Analysis
5. PET medical image analysis improved in order to optimize radiotherapy treatments
6. Laboratory Automation Market: 2017 Equipment & Software, Drug Discovery, Clinical Diagnostics, Genomics & Proteomics Analysis in New Research Reports at RnRMarketResearch
7. BenefitMall Launches New Health Care Reform Compliance Analysis Tool, allCheck
8. Market for U.S. Disposable Syringe & BRICS General & Specialized Syringes Analysis in New Research Report at ReportsnReports.com
9. General Laboratory Equipment Market Analysis and 2017 Forecast in New Research Report at ReportsnReports.com
10. US Drug Watchdog Now Urges All US Citizens with a Metal Hip Implant to get Blood Tests for Cobalt & Chromium and They Now Offer a No Cost Analysis to Check for a Failure
11. Attention Deficit Hyperactivity Disorder Market (ADHD) Analysis & 2018 Forecasts in New Research Report at RnRMarketResearch.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Diego, California (PRWEB) May 29, 2015 A ... Core” and have joined the national effort to teach this ... parents in the U.S. have been “sickened” by the recent ... However, love it or hate it, Common Core is now ... District of Columbia. Parents are now seeking ways to ...
(Date:5/29/2015)... The print component of “Skin Health” is ... 250,000 and an estimated readership of 750,000. The digital ... strategy, and across a network of top news sites ... the campaign, click here. , Lucy Liu ... actress, model and producer details her skin care routine, ...
(Date:5/29/2015)... Chicago, Ill (PRWEB) May 29, 2015 ... Care , a dozen medical pioneers recognized by a ... changed the course of cancer treatment. Honorees will be ... of Cancer Care™ Award Ceremony, held 8:30-11:00 p.m. CDT ... , The 2015 honorees are being recognized for groundbreaking ...
(Date:5/29/2015)... Oaksterdam University, the first cannabis college in America, will ... popular and highly demanded Basic and Advanced Classic Seminars ... to 5:30 pm each day. Certification is available upon completion of ... held on June 14 from 12:00 pm to 6:00 pm. Both ... Plaza Hotel & Casino in downtown Las Vegas. , ...
(Date:5/29/2015)... Designed with the versatile athlete in mind, ... all new, exclusive line of supplementation called The 24/7 ... and greatest, high impact, result driven ingredients that have ... 24/7 Series can be used by anyone from bodybuilders ... fitness enthusiasts. There are no stimulant based ingredients that ...
Breaking Medicine News(10 mins):Health News:Doctors Discover a Cure for the Common Core 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 2Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 3Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3
... seen with cirrohosis but aren,t sensitive enough , , ... to detect esophageal bleeding in people with cirrhosis show ... researchers. , About 25 percent of patients with cirrhosis ... veins commonly seen with cirrhosis. Variceal bleeding can cause ...
... movement, serious complications can follow, experts note , , TUESDAY, ... identified a marker that might predict which pregnant women ... essentially a baby,s first bowel movement, excreted in the ... is considered a sign of fetal distress. A small ...
... London, New Delhi, and Singapore (6 May, 2008) ... manage patients with depression has challenged the rationale behind ... behavioural therapy (CBT) for milder depression. , According ... is a lack of evidence for CBT being more ...
... with state and local public health agencies for,Community ... The Community Coalitions Health,Institute (CCHI), a 501(c)(3) affiliate ... that it has received a five-year grant from ... improvement in,community health systems across the country. The ...
... WHAT: On national grassroots lobby day, Lance Armstrong to visit four ... * TUESDAY, MAY 13, 2008 WHERE: Tour of Ralph ... (RLC) and RLC Fifth Anniversary Celebration at the Marcus ... 1919 Madison Avenue (Entrance on 124th Street) ...
... WASHINGTON, May 6 The latest,"gaming for health" ... games (e.g., a "disease" being unleashed inadvertently,on the ... videogames,used to train emergency medical personnel -- will ... event at 1 p.m. EDT Thursday,(May 8, 2008)., ...
Cached Medicine News:Health News:Noninvasive Procedures Show Promise for Esophageal Bleeding 2Health News:Doctors Discover Marker for Meconium Passage During Delivery 2Health News:Antidepressants do work in depression while evidence for CBT is poorer say experts 2Health News:Antidepressants do work in depression while evidence for CBT is poorer say experts 3Health News:NBCH's Community Coalitions Health Institute Receives CDC Grant 2Health News:Lance Armstrong Marks 5th Annual LIVESTRONG(TM) Day with Nationwide Fly-Around 2Health News:Video Gaming for Health: Major New Trends to Be Discussed as National Conference Gets Underway 2
(Date:5/29/2015)... British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... at the American Association of Cancer Research ... on the potential for its lead product candidate ...
(Date:5/29/2015)... May 29, 2015 Amgen (NASDAQ: ... pivotal Phase 3, global, randomized, placebo-controlled trials evaluating ... of secondary hyperparathyroidism (SHPT) in patients with chronic ... the primary endpoint, demonstrating that a greater proportion ... a greater than 30 percent reduction in parathyroid ...
(Date:5/28/2015)... INDIANAPOLIS , May 28, 2015  Eli Lilly and ... of its previously announced cash tender offer for up to ... debt securities. Holders of notes who tendered, and ... p.m., New York City time, on ... accepted for purchase by Lilly, are eligible to receive the ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5
... , SAN DIEGO , Jan. ... has significantly enhanced its ability to treat breast cancer with the ... will be among the first in the nation to use both ... to optimize their therapy treatment. , AccuBoost is a technique for ...
... PHILADELPHIA and LONDON , Jan. 20 , ... , 13,500 malaria compounds to be made freely available ... tropical diseases , Pledge to create sustainable pricing model ... African Malaria Partnership awards four new grants worth $2.5m ...
Cached Medicine Technology:First Coast Oncology Deploying Both Naviscan(TM) PEM and AccuBoost(TM) Assisted Therapy to Optimize Breast Cancer Treatment 2First Coast Oncology Deploying Both Naviscan(TM) PEM and AccuBoost(TM) Assisted Therapy to Optimize Breast Cancer Treatment 3GSK Announces 'Open Innovation' Strategy to Help Deliver New and Better Medicines for People Living in the World's Poorest Countries 2GSK Announces 'Open Innovation' Strategy to Help Deliver New and Better Medicines for People Living in the World's Poorest Countries 3GSK Announces 'Open Innovation' Strategy to Help Deliver New and Better Medicines for People Living in the World's Poorest Countries 4GSK Announces 'Open Innovation' Strategy to Help Deliver New and Better Medicines for People Living in the World's Poorest Countries 5
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: